Insider trades
Lloyd Mitchell Segal, Director of Aktis Oncology AKTS, has filed 0 purchases and 6 sales on the open market. The latest trade was on 01/12.
Lloyd Mitchell Segal
Director
- Company
- Aktis Oncology AKTS
- First filing
- 23/02/01
- Trades
- 15 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- No record
- Last trade
- 01/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/03/12 | 25/03/14 | 21,179 sh | $1.14 | $24,144.06 | −14.5% | |
| Open-market sale10b5-1 plan | 24/03/28–24/04/01 | 24/04/01 | 5,141 sh2 trades | $4.62avg. | $23,776.33 | −4.6% | |
| Open-market sale10b5-1 plan | 24/03/25–24/03/27 | 24/03/27 | 7,950 sh3 trades | $4.69avg. | $37,259 | −8.7% |